Remove 2007 Remove Portfolio Remove Valuation
article thumbnail

2024 Insurance M&A Market Update: Robust But Complicated

Sica Fletcher

As the charts below indicate, what used to make up approximately 10% of the total buyer space now takes up a whopping 75% of the market: Private Equity in Insurance, 2007 vs. 2024 The growth of private equity in the insurance M&A market can be attributed to equal parts reaction to it and reflection of it. for insurance agencies.

M&A 52
article thumbnail

Collateralized Debt Obligation (CDO)

Wall Street Mojo

CDOs provide investors with a diversified portfolio of debt instruments across different risk levels. Unlock the art of financial modeling and valuation with a comprehensive course covering McDonald’s forecast methodologies, advanced valuation techniques, and financial statements. read more , etc. read more , etc.

Debt 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2023 Third Quarter Review & Commentary

FineMark

Rather than trying to predict the future, we prefer to construct solid portfolios, focus on longer-term investable themes, and identify third-party manager talent with demonstrable (and persistent) alpha-generation ability. Looking ahead, we believe history will regard the 2007-2021 time period as anomalous.

S&P 52
article thumbnail

The Complete Guide to Technology Private Equity

Mergers and Inquisitions

Loose Monetary and Fiscal Policy – Zero and negative interest rates and massive money printing tend to inflate valuations the most for high-risk, high-growth companies. Smaller firms in this category often focus on organic growth and bolt-on acquisitions to scale their portfolio companies.

article thumbnail

Healthcare 2021: Trends, M&A & Valuations

InvestmentBank.com

Today, there is a movement towards utilizing molecular diagnostics and personalized medicine making a diverse portfolio of products critical. How do business valuations differ in Healthcare and across its subsectors? However, Medtronic’s valuation is significantly lower than the sector average (Collins). Anthony Ledesma et al.,